An Investigation of Premama Balance and Its Effects on Hormonal Imbalances

NCT ID: NCT05518006

Last Updated: 2024-04-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2022-12-30

Study Completion Date

2023-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An investigation of the dietary supplement marketed as "Premama Balance" on markers of subjective wellbeing in trial participants such as common symptoms of PMS and menstrual symptoms, as well as its effects on aiding in returning to their perceived regular/normal menstrual cycle.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

PMS Menstrual Discomfort Hormone Disturbance Menstrual Pain Menstrual Irregularity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PreMama Balance

Each day, the participants will take 1 packet of Premama Balance, dissolved in one glass (8oz+) of water. Premama Balance may be taken with or without food. Should participants present themselves with a sensitive stomach, it is recommended to take the drink with or after a meal to avoid an upset stomach. Participants will repeat this process daily for 6 months/24 weeks (study period) until the study is complete.

At week 12 and in week 24, the participants will take a survey and a hormone test to track progress. In total there will be 3 surveys and 3 hormone tests. Additionally, participants will fill out a weekly consumption survey to track compliance.

Group Type EXPERIMENTAL

PreMama Balance

Intervention Type DIETARY_SUPPLEMENT

Premama Balance is a blend of the following: Vitex (Chasteberry Extract), commonly used to help regulate hormones; Antioxidants, Selenium, and Magnesium, also help support the cleansing of hormonal birth control from the liver and help strengthen the uterine lining.

Placebo Drink

Each day, the participants will take 1 packet of Placebo Drink, dissolved in one glass (8oz+) of water. Placebo Drink may be taken with or without food. Should participants present themselves with a sensitive stomach, it is recommended to take the drink with or after a meal to avoid an upset stomach. Participants will repeat this process daily for 6 months/24 weeks (study period) until the study is complete.

At week 12 and in week 24, the participants will take a survey and a hormone test to track progress. In total there will be 3 surveys and 3 hormone tests. Additionally, participants will fill out a weekly consumption survey to track compliance.

Group Type PLACEBO_COMPARATOR

Placebo Drink

Intervention Type DIETARY_SUPPLEMENT

Blended Placebo drink

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PreMama Balance

Premama Balance is a blend of the following: Vitex (Chasteberry Extract), commonly used to help regulate hormones; Antioxidants, Selenium, and Magnesium, also help support the cleansing of hormonal birth control from the liver and help strengthen the uterine lining.

Intervention Type DIETARY_SUPPLEMENT

Placebo Drink

Blended Placebo drink

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must be in good health (don't report any medical conditions asked in the screening questionnaire)
* Must be on hormonal birth control (containing both progesterone and estrogen) for the past 6 months \& willing to stop using it to participate in the study
* Must be willing to get off of hormonal birth control for the study period
* Must be able to track their menstrual cycle
* BMI under 40
* Agree to refrain from any lifestyle changes that may affect their menstrual cycle for the duration of the study
* Willingness to adhere to the dietary supplement regimen
* Willingness to refrain from any other dietary supplements targeting the menstrual cycle and hormone control during the study period
* Is able to communicate in English
* Is willing and able to share feedback via the used technology portal
* Must provide written informed consent (ICF)

Exclusion Criteria

* History of oncological (including ovarian cancer) or psychiatric conditions
* History of uncontrolled health conditions
* History of hysterectomy or ovariectomy
* History of diabetes \& thyroid disorders
* Smoker
* More than 3 servings of alcohol a day
* Undergoing hormonal therapy of any kind
* Menopausal or peri-menopausal
* Not starting any other form of contraceptive other than condoms, abstinence, planned sexual intercourse
* Usage of any medication or herbal remedies/supplements which can affect the menstrual cycle or hormonal balance
* If currently taking allowed supplements, the dosage needs to remain the same throughout the entirety of the study
Minimum Eligible Age

20 Years

Maximum Eligible Age

42 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Citruslabs

INDUSTRY

Sponsor Role collaborator

Premama Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Susanne Mitschke

Role: PRINCIPAL_INVESTIGATOR

Citruslabs

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20223

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Progesterone in Luteal Phase Deficiency
NCT02950948 WITHDRAWN PHASE3